`
`NOTE: This order is nonprecedential.
`
`United States Court of Appeals
`for the Federal Circuit
`______________________
`
`VANDA PHARMACEUTICALS INC.,
`Plaintiff-Appellant
`
`v.
`
`TEVA PHARMACEUTICALS USA, INC., APOTEX
`INC., APOTEX CORP.,
`Defendants-Appellees
`______________________
`
`2023-1247
`______________________
`
`Appeal from the United States District Court for the
`District of Delaware in Nos. 1:18-cv-00651-CFC, 1:18-cv-
`00689-CFC, 1:19-cv-00560-CFC, 1:19-cv-00685-CFC, 1:19-
`cv-02202-CFC, 1:19-cv-02375-CFC, 1:20-cv-00083-CFC,
`1:20-cv-00093-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-
`CFC, 1:21-cv-00121-CFC, and 1:21-cv-00282-CFC, Chief
`Judge Colm F. Connolly.
`______________________
`
`ON MOTION
`______________________
`
`PER CURIAM.
`
`O R D E R
`Upon consideration of Teva Pharmaceuticals USA,
`Inc.’s submission docketed at ECF Nos. 9 and 10, seeking
`
`
`
`
`
`
`
`Case: 23-1247 Document: 12 Page: 2 Filed: 12/19/2022
`
`
`2
`
`VANDA PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS
`USA, INC.
`
`reconsideration or modification of the court’s order dock-
`eted at ECF No. 6, granting a temporary injunction
`pending review of Vanda Pharmaceuticals Inc.’s Rule 8
`motion,
`
`IT IS ORDERED THAT:
`
`Responses to ECF Nos. 9 and 10 are due no later than
`Wednesday, December 21, 2022, at noon Eastern time.
`Any reply in support of ECF Nos. 9 and 10 is due no later
`than Thursday, December 22, 2022, at 3:00pm Eastern
`time.
`
`
`
`December 19, 2022
` Date
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` FOR THE COURT
`
` /s/ Peter R. Marksteiner
` Peter R. Marksteiner
` Clerk of Court
`
`
`